2025年3月4日，强生医疗科技旗下的Shockwave Medical公司宣布，正式在美国市场推出其创新的Javelin外周血管内冲击波碎石（IVL）导管。这一新品的推出，标志着在解决外周动脉疾病（PAD）患者治疗难题上迈出了关键一步。

At the company’s annual Capital Markets Day in Bangkok today, Mr. Aloke Lohia, Group CEO of Indorama Ventures, outlined the ...

Johnson & Johnson MedTech‘s Shockwave Medical announced the U.S. launch of its Javelin peripheral intravascular lithotripsy ...

为探究静脉内平滑肌瘤病（IVL）的发病机制，复旦大学附属中山医院的研究人员开展多组学研究，揭示其病理和分子变化，发现 10q 染色体缺失和血管形态可预测侵袭性，为新疗法奠定基础。

Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral ...

Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, ...

Indorama Ventures pivoted towards a seismic, generational change in the chemical industry, which is being irrevocably shaped ...